The WACC of Tmc Life Sciences Berhad (TMCLIFE.KL) is 7.7%.
| Range | Selected | |
| Cost of equity | 6.40% - 10.70% | 8.55% |
| Tax rate | 25.20% - 27.30% | 26.25% |
| Cost of debt | 4.20% - 7.40% | 5.80% |
| WACC | 5.8% - 9.6% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.8% | 4.3% |
| Equity market risk premium | 6.9% | 7.8% |
| Adjusted beta | 0.39 | 0.75 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.40% | 10.70% |
| Tax rate | 25.20% | 27.30% |
| Debt/Equity ratio | 0.26 | 0.26 |
| Cost of debt | 4.20% | 7.40% |
| After-tax WACC | 5.8% | 9.6% |
| Selected WACC | 7.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for TMCLIFE.KL:
cost_of_equity (8.55%) = risk_free_rate (4.05%) + equity_risk_premium (7.35%) * adjusted_beta (0.39) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.